Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II

SF Zhou - Clinical pharmacokinetics, 2009 - Springer
Part I of this article discussed the potential functional importance of genetic mutations and
alleles of the human cytochrome P450 2D6 (CYP2D6) gene. The impact of CYP2D6 …

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis

A Mészáros, P Czobor, S Bálint… - International journal …, 2009 - academic.oup.com
Our objective was to conduct a meta-analysis of therapeutic efficacy of pharmacological
treatment of adult ADHD based on data from controlled clinical trials. We used the search …

Stereospecific nucleophilic substitution with arylboronic acids as nucleophiles in the presence of a CONH group

D Tian, C Li, G Gu, H Peng, X Zhang… - Angewandte Chemie …, 2018 - Wiley Online Library
Stereospecific nucleophilic substitution was achieved for the first time with arylboronic acids
as nucleophiles. This transition‐metal‐free coupling between chiral α‐aryl‐α‐mesylated …

Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development

SF Zhou, JP Liu, XS Lai - Current medicinal chemistry, 2009 - ingentaconnect.com
CYP2D6 accounts for only a small percentage of total hepatic CYPs (100) with significant
polymorphisms. A number of drugs acting on the central nervous system and cardiovascular …

General synthesis of chiral α, α-diaryl carboxamides by enantioselective palladium-catalyzed cross-coupling

B Li, MA Aliyu, Z Gao, T Li, W Dong, J Li, E Shi… - Organic …, 2020 - ACS Publications
A general synthesis of chiral α, α-diaryl carboxamides is developed by enantioselective
cross-coupling between 2-bromo-2-aryl carboxamides and arylboronic acids, leading to a …

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review

P Hammerness, K McCarthy, E Mancuso… - Neuropsychiatric …, 2009 - Taylor & Francis
Objective: This review examines and summarizes the pharmacodynamic and
pharmacokinetic properties, short-and longer-term efficacy, the moderating effect of …

Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites

JY Byeon, YH Kim, HS Na, JH Jang, SH Kim… - Archives of pharmacal …, 2015 - Springer
To investigate the effect of the variant CYP2D6* 10 allele on the pharmacokinetics of
atomoxetine and its metabolites, 4-hydroxyatomoxetine (4-HAT) and N …

Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: results of a pilot study

M Maziade, N Rouleau, B Lee, A Rogers… - Journal of child and …, 2009 - liebertpub.com
This pilot longitudinal study using measures from parents and teachers evaluated the effects
of flexible doses of atomoxetine (ATX) on neuropsychological and functional outcomes in 21 …

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a …

G Dell'Agnello, D Maschietto, C Bravaccio… - European …, 2009 - Elsevier
OBJECTIVE: The primary aim of this study was to assess the efficacy of atomoxetine in
improving ADHD and ODD symptoms in paediatric patients with ADHD and comorbid …

CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD

PT Trzepacz, DW Williams, PD Feldman… - European …, 2008 - Elsevier
To determine whether physicians can adequately titrate atomoxetine without knowing
genotype status for hepatic cytochrome P450 2D6, we pooled data from two open-label …